| Product Code: ETC7622577 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Ireland continued to see a high concentration of import shipments for adeno-associated virus vector manufacturing, with the top exporting countries being the USA, UK, Germany, Metropolitan France, and Serbia. Despite a negative CAGR of -4.18% from 2020 to 2024 and a significant decline in growth rate of -30.16% from 2023 to 2024, the market remains competitive and dynamic. This indicates a challenging landscape for manufacturers and underscores the importance of strategic planning and innovation to stay ahead in the evolving industry.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Adeno Associated Virus Vector Manufacturing Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Adeno Associated Virus Vector Manufacturing Market - Industry Life Cycle |
3.4 Ireland Adeno Associated Virus Vector Manufacturing Market - Porter's Five Forces |
3.5 Ireland Adeno Associated Virus Vector Manufacturing Market Revenues & Volume Share, By Scale of Operations, 2021 & 2031F |
3.6 Ireland Adeno Associated Virus Vector Manufacturing Market Revenues & Volume Share, By Therapeutic Area Scope, 2021 & 2031F |
3.7 Ireland Adeno Associated Virus Vector Manufacturing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Ireland Adeno Associated Virus Vector Manufacturing Market Revenues & Volume Share, By Method Scope, 2021 & 2031F |
4 Ireland Adeno Associated Virus Vector Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Ireland Adeno Associated Virus Vector Manufacturing Market Trends |
6 Ireland Adeno Associated Virus Vector Manufacturing Market, By Types |
6.1 Ireland Adeno Associated Virus Vector Manufacturing Market, By Scale of Operations |
6.1.1 Overview and Analysis |
6.1.2 Ireland Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Scale of Operations, 2021- 2031F |
6.1.3 Ireland Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Clinical, 2021- 2031F |
6.1.4 Ireland Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Preclinical, 2021- 2031F |
6.1.5 Ireland Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Commercial, 2021- 2031F |
6.2 Ireland Adeno Associated Virus Vector Manufacturing Market, By Therapeutic Area Scope |
6.2.1 Overview and Analysis |
6.2.2 Ireland Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Hematological Diseases, 2021- 2031F |
6.2.3 Ireland Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.4 Ireland Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Genetic Disorders, 2021- 2031F |
6.2.5 Ireland Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Neurological Disorders, 2021- 2031F |
6.2.6 Ireland Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Ophthalmic Disorders, 2021- 2031F |
6.3 Ireland Adeno Associated Virus Vector Manufacturing Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Ireland Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.3.3 Ireland Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.3.4 Ireland Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Vaccine, 2021- 2031F |
6.4 Ireland Adeno Associated Virus Vector Manufacturing Market, By Method Scope |
6.4.1 Overview and Analysis |
6.4.2 Ireland Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By In Vitro, 2021- 2031F |
6.4.3 Ireland Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By In Vivo, 2021- 2031F |
7 Ireland Adeno Associated Virus Vector Manufacturing Market Import-Export Trade Statistics |
7.1 Ireland Adeno Associated Virus Vector Manufacturing Market Export to Major Countries |
7.2 Ireland Adeno Associated Virus Vector Manufacturing Market Imports from Major Countries |
8 Ireland Adeno Associated Virus Vector Manufacturing Market Key Performance Indicators |
9 Ireland Adeno Associated Virus Vector Manufacturing Market - Opportunity Assessment |
9.1 Ireland Adeno Associated Virus Vector Manufacturing Market Opportunity Assessment, By Scale of Operations, 2021 & 2031F |
9.2 Ireland Adeno Associated Virus Vector Manufacturing Market Opportunity Assessment, By Therapeutic Area Scope, 2021 & 2031F |
9.3 Ireland Adeno Associated Virus Vector Manufacturing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Ireland Adeno Associated Virus Vector Manufacturing Market Opportunity Assessment, By Method Scope, 2021 & 2031F |
10 Ireland Adeno Associated Virus Vector Manufacturing Market - Competitive Landscape |
10.1 Ireland Adeno Associated Virus Vector Manufacturing Market Revenue Share, By Companies, 2024 |
10.2 Ireland Adeno Associated Virus Vector Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here